Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786381 · ClinicalTrials.gov registry record
Idylla IFV-RSV Panel Clinical Testing
A clinical trial, sponsored by Janssen Pharmaceutica N.V., Belgium.
- Completed
- Registry status
- 213
- Enrollment target
NCT02786381: Completed study, sponsored by Janssen Pharmaceutica N.V., Belgium.
NCT02786381 is a clinical trial that has completed, run by Janssen Pharmaceutica N.V., Belgium. The registered enrollment target is 213 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02786381 has completed, sponsored by Janssen Pharmaceutica N.V., Belgium.
- COMPLETED
- Registry status
- 213 participants
- Enrollment target
Study Summary
This clinical study will collect fresh samples and perform laboratory testing on fresh and archived samples as described in the protocol.
Primary Outcome
Product Performance will be assessed based on samples collected in 2015/2016 season (average of 6 months) and archived samples.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-10 |
What the finished NCT02786381 record still lists
NCT02786381 is an observational study that tracks outcomes without assigning an intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02786381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02786381 about?
NCT02786381 is a clinical study titled "Idylla IFV-RSV Panel Clinical Testing". This clinical study will collect fresh samples and perform laboratory testing on fresh and archived samples as described in the protocol.
What is the current status of trial NCT02786381?
This trial is currently completed. The enrollment target is 213 participants. The study started on 2015-11. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02786381?
This trial is sponsored by Janssen Pharmaceutica N.V., Belgium, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia